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Carbohydrates fulfill many roles in biological systems including (but not limited to): 
acting ascellular structural support, mediating cellsignaling and acting as an energy supply. They 
can also act as “superantigens” for the immune system whenpart of certain fat molecules called 
glycosphingolipids. These molecules are able to activateinvariant Natural Killer T-Cells (iNKT 
cells); white blood cells that mount a dangerous, non-specificsystemic immune response 
potentially leading to cell death. However, this same immune response (if controlled), has 
promise to act as a last line antiviral and/or a potential anticancer agent by potentially turning the 
immune system against a previously ignored virus, infection or tumour. The identification and 
synthesis of such immunoactive agents for clinical and mechanistic applications is of great 
interest in carbohydrate immunology. KRN7000 is of particular interest. It was first isolated 
from a marine sponge, and is the most potent activator of iNKT cells. However, if almost any 
part of the molecule is modified, all biological activity is lost. One of the few exceptions, is that 
the enzymatically-sensitive bond attaching the sugar to the lipid can be replaced with a stable 
carbon linkage. However, the synthesis is too long to be commercially useful. We wish to 
discuss our approach towards this molecule that attempts to streamline the approach by very 
subtly modifying KRN7000 in a new way. The synthesis, and its implications for biological 
activity, will be discussed. 
 
